About
OrthoTreat believes in empowering healing from within, restoring strength and resilience to people affected by bone-related conditions. Our purpose is to transform lives by tackling one of the most complex challenges in medicine: true bone regeneration.
We've formulated a unique approach, carefully overseeing and modulating the complex processes involved in bone regeneration. By creating a balanced system that precisely controls the immune response, inflammation, and growth factor secretion, we enable natural healing processes to work safely and effectively.
Our flagship product, ModulX, is a dual-drug combination administered as a controlled-release, localized injection with minimal risk factors. ModulX’s sophisticated design accelerates healing, improves bone quality, and offers a new level of care for those in need. With this breakthrough, we’re setting a new standard in bone regeneration, supporting individuals globally in reclaiming mobility and quality of life.
Funding history · 2 rounds · — total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is OrthoTreat's primary focus?
- OrthoTreat specializes in bone regeneration solutions, aiming to restore strength and resilience to individuals with bone-related conditions through a unique approach that modulates immune response, inflammation, and growth factor secretion.
- What is OrthoTreat's flagship product?
- OrthoTreat's flagship product is ModulX, a dual-drug combination delivered as a controlled-release, localized injection designed to accelerate healing and improve bone quality.
- When was OrthoTreat founded?
- OrthoTreat was founded in November 2020.
- What was OrthoTreat's most recent funding round?
- OrthoTreat completed a Seed funding round in July 2023. For full financing history, please refer to startupim.
- Has OrthoTreat received any grants?
- Yes, OrthoTreat received a grant from the IIA in July 2024.
- How many employees does OrthoTreat currently have?
- OrthoTreat currently has 11 employees.
- Where is OrthoTreat headquartered?
- OrthoTreat is headquartered in Tel Aviv-Yafo, Israel.
- What recognition did OrthoTreat receive in 2024?
- OrthoTreat was recognized as a winner in the Healthcare & Pharmaceuticals Awards in January 2025 for 2024.
- What is the current product stage of ModulX?
- ModulX is currently in the research and development (R&D) stage.